Skip to main content
. 2023 Apr 25;23:209. doi: 10.1186/s12872-023-03236-5

Table 2.

Drug prescription pattern according to chronic kidney disease grade

CKD Grade 1 2 3 4 5 p
(n = 3096) (n = 5420) (n = 3338) (n = 482) (n = 378)
Aspirin 1535 (49.6) 2565 (47.3) 1461 (43.8) 218 (45.2) 187 (49.5) < 0.001
Clopidogrel 562 (18.2) 994 (18.3) 590 (17.7) 121 (25.1) 110 (29.1) < 0.001
Beta blocker 1262 (40.8) 2182 (40.3) 1342 (40.2) 168 (34.9) 136 (36.0) 0.066
Calcium channel blocker 644 (20.8) 1233 (22.7) 731 (21.9) 101 (21.0) 81 (21.4) 0.314
Digoxin 456 (14.7) 1064 (19.6) 962 (28.8) 120 (24.9) 37 (9.8) < 0.001
Amiodarone 603 (19.5) 989 (18.2) 707 (21.2) 139 (28.8) 116 (30.7) < 0.001
Class Ic AAD 1317 (42.5) 1743 (32.2) 585 (17.5) 37 (7.7) 39 (10.3) < 0.001
Anticoagulants 1061 (34.3) 1966 (36.3) 1224 (36.7) 134 (27.8) 62 (16.4)
Warfarin 871 (82.1) 1668 (84.8) 1047 (85.5) 122 (91.0) 60 (96.8) 0.002
NOAC 190 (17.9) 298 (15.2) 177 (14.5) 12 (9.0) 2 (3.2)

Dabigatran

Rivaroxaban

Apixaban

Edoxaban

107 (56.3)

51 (26.8)

31(16.3)

1 (0.5)

125 (41.9)

109 (36.6)

64 (21.5)

0 (0.0)

58 (32.8)

86 (48.6)

32 (18.1)

1 (0.6)

3 (25.0)

4 (33.3)

5 (41.7)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100.0)

0 (0.0)

< 0.001

Data are presented as a number (%)

CKD: Chronic kidney disease, AAD: Antiarrhythmic drug, NOAC: Non-vitamin K oral anticoagulants